A randomized, blind, active-controlled trials to evaluate the safety and immunogenicity of freeze-dried rabies vaccine (vero cell) for Human use in the healthy subjects among 10 to 50 years old

Trial Profile

A randomized, blind, active-controlled trials to evaluate the safety and immunogenicity of freeze-dried rabies vaccine (vero cell) for Human use in the healthy subjects among 10 to 50 years old

Completed
Phase of Trial: Phase III

Latest Information Update: 09 May 2016

At a glance

  • Drugs Rabies vaccine (Primary)
  • Indications Rabies
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Jiangsu Simcere Pharmaceutical
  • Most Recent Events

    • 29 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top